Schedule 13G ownership disclosure
ARCA biopharma, Inc.
Security class unavailable · CUSIP: 00211Y100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,000,000
- Percent of class
- 14.1800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001136261-15-000001
- Form type
- SC 13G
- Filer
- Oruka Therapeutics, Inc.
- CIK
- CIK 907654
- Filed
- Jan 05, 2015
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership